Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
Irene Ruiz‐DeDiego(Consejo Superior de Investigaciones Científicas), Rosario Moratalla(Instituto Cajal)
Cited by 14
Related Papers
L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice
|Biological Psychiatry|2013|177
Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining
|Neuropsychopharmacology|2013|148
Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D<sub>1</sub>R Null,<i>Drd1a</i><sup>−/−</sup>Mice and in Hippocampal siRNA Silenced<i>Drd1a</i>Mice
|Journal of Neuroscience|2010|141
Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation
|Frontiers in Neuroanatomy|2011|105
Methamphetamine and Parkinson's Disease
|Parkinson s Disease|2013|83